Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    June 2017
  1. HUANG H, Darbar D
    Genetic heterogeneity of atrial fibrillation susceptibility loci across racial or ethnic groups.
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed     Text format    


  2. DIENER HC
    Does atrial fibrillation lead to cognitive decline and dementia?
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed     Text format    


    May 2017
  3. LUSCHER TF
    Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy.
    Eur Heart J. 2017;38:1443-1446.
    PubMed     Text format    


    April 2017
  4. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. LEE JY, Kim TH, Yang PS, Lim HE, et al
    Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility loci.
    Eur Heart J. 2017 Apr 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  6. RAHIMI K
    Subclinical atrial fibrillation in need of more assertive evidence.
    Eur Heart J. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format    



  7. Corrigendum to: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS'.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format    


  8. CAMM AJ, Savelieva I
    Female gender as a risk factor for stroke associated with atrial fibrillation.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format    


  9. LUSCHER TF
    Atrial fibrillation and thrombo- embolism: anticoagulants or devices?
    Eur Heart J. 2017;38:839-842.
    PubMed     Text format    


  10. ABDUL-RAHIM AH, Perez AC, MacIsaac RL, Jhund PS, et al
    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
    Eur Heart J. 2017;38:742-750.
    PubMed     Text format     Abstract available


  11. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  12. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. AKDIS D, Saguner AM, Shah K, Wei C, et al
    Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.
    Eur Heart J. 2017 Feb 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. BACANOVIC S, Steffen C, Benz DC, Kaufmann PA, et al
    Third-degree atrioventricular block: tip of the iceberg of a systemic disease.
    Eur Heart J. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


    January 2017
  15. GADSBOLL K, Staerk L, Fosbol EL, Sindet-Pedersen C, et al
    Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Eur Heart J. 2017 Jan 21. pii: ehw658. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. SCHWARTZ PJ
    Evolving concepts for the Long QT Syndrome.
    Eur Heart J. 2017;38:225-226.
    PubMed     Text format    


  17. STEFFEL J
    The Subcutaneous Implantable Cardioverter Defibrillator.
    Eur Heart J. 2017;38:226-228.
    PubMed     Text format    


  18. MCLEOD CJ, Boersma L, Okamura H, Friedman PA, et al
    The subcutaneous implantable cardioverter defibrillator: state-of-the-art review.
    Eur Heart J. 2017;38:247-257.
    PubMed     Text format    


  19. ARBELO E, Brugada J, Lundqvist CB, Laroche C, et al
    Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry.
    Eur Heart J. 2017 Jan 18. pii: ehw564. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. RENOUX C, Coulombe J, Suissa S
    Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.
    Eur Heart J. 2017 Jan 10. pii: ehw613. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. BAVENDIEK U, Aguirre Davila L, Koch A, Bauersachs J, et al
    Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.
    Eur Heart J. 2017 Jan 8. pii: ehw577. doi: 10.1093.
    PubMed     Text format    


  22. CHATTERJEE NA, Borgquist R, Chang Y, Lewey J, et al
    Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.
    Eur Heart J. 2017 Jan 8. pii: ehw598. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. FANOLA CL, Giugliano RP, Ruff CT, Trevisan M, et al
    A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
    Eur Heart J. 2017 Jan 6. pii: ehw565. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. SCHMIDT C, Wiedmann F, Zhou XB, Heijman J, et al
    Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
    Eur Heart J. 2017 Jan 4. pii: ehw559. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. NATTEL S
    Close connections between contraction and rhythm: a new genetic cause of atrial fibrillation/cardiomyopathy and what it can teach us.
    Eur Heart J. 2017;38:35-37.
    PubMed     Text format    


  26. GRACE A, Verma A, Willems S
    Dipole Density Mapping of Atrial Fibrillation.
    Eur Heart J. 2017;38:5-9.
    PubMed     Text format    


  27. LIP GY
    Stroke prevention in Atrial Fibrillation.
    Eur Heart J. 2017;38:4-5.
    PubMed     Text format    


  28. LUSCHER TF
    Atrial fibrillation beyond the arrhythmia: hypercoagulability, adipose tissue, and fibrotic remodelling.
    Eur Heart J. 2017;38:1-3.
    PubMed     Text format    


    December 2016
  29. NYNS EC, Kip A, Bart CI, Plomp JJ, et al
    Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
    Eur Heart J. 2016 Dec 23. pii: ehw574. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. DURU F, Brunckhorst C
    Zurich International Symposium on Arrhythmogenic Right Ventricular Cardiomyopathies.
    Eur Heart J. 2016;37:3555-3556.
    PubMed     Text format    


  31. WAHBI K, Babuty D, Probst V, Wissocque L, et al
    Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  32. WAHBI K, Babuty D, Probst V, Wissocque L, et al
    Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Eur Heart J. 2016 Dec 9. doi: 10.1093.
    PubMed     Text format    


    October 2016
  33. HALVORSEN S, Storey RF, Rocca B, Sibbing D, et al
    Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.
    Eur Heart J. 2016.
    PubMed     Text format    


  34. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  35. GUDBJARTSSON DF, Holm H, Sulem P, Masson G, et al
    A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  36. STAERK L, Fosbol EL, Lip GY, Lamberts M, et al
    Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available



  37. Yoga and atrial fibrillation.
    Eur Heart J. 2016;37:2855.
    PubMed     Text format    



  38. 'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation.
    Eur Heart J. 2016;37:2853.
    PubMed     Text format    



  39. What's new in the 2016 ESC Guidelines on atrial fibrillation?
    Eur Heart J. 2016;37:2851-2852.
    PubMed     Text format    


  40. LUSCHER TF
    Atrial fibrillation: today's guideline-based management.
    Eur Heart J. 2016;37:2847-2850.
    PubMed     Text format    


    September 2016
  41. IBRAHIM T, Dommasch M, Huber A, Hoppmann P, et al
    Percutaneous revascularization of concurrently obstructed left-sided pulmonary veins complicating catheter ablation for atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format    


  42. ZAMORANO JL
    Specific risk of atrial fibrillation and stroke in oncology patients.
    Eur Heart J. 2016;37:2747-2748.
    PubMed     Text format    


  43. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
    Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
    Eur Heart J. 2016.
    PubMed     Text format    


    August 2016
  44. KIRCHHOF P, Benussi S, Kotecha D, Ahlsson A, et al
    2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the Eur
    Eur Heart J. 2016.
    PubMed     Text format    


  45. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed     Text format    


    July 2016
  46. BUNCH TJ, May HT
    Atrial fibrillation: a risk factor or risk marker?
    Eur Heart J. 2016.
    PubMed     Text format    


  47. LAU DH, Middeldorp ME, Sanders P
    Obesity paradox in atrial fibrillation: a distracting reality or fictitious finding?
    Eur Heart J. 2016.
    PubMed     Text format    


  48. KIRCHHOF P, Calkins H
    Catheter ablation in patients with persistent atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  49. KUCK KH, Furnkranz A, Chun KR, Metzner A, et al
    Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  50. BASSAND JP, Accetta G, Camm AJ, Cools F, et al
    Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  51. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
    Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  52. FERREIRA JP, Girerd N, Alshalash S, Konstam MA, et al
    Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  53. LUSCHER TF
    Atrial fibrillation: novel risk factors, mechanisms and ablation techniques.
    Eur Heart J. 2016;37:1553-5.
    PubMed     Text format    


    April 2016
  54. BADIMON L, Cubedo J
    Hypercoagulability and atrial fibrillation: a two-way road?
    Eur Heart J. 2016.
    PubMed     Text format    


  55. SPRONK HM, De Jong AM, Verheule S, De Boer HC, et al
    Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  56. SANDHU RK, Ezekowitz J, Andersson U, Alexander JH, et al
    The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  57. NIELSEN JC, Gerdes JC
    Does catheter ablation reduce mortality and stroke in patients with atrial fibrillation? Patient selection or causality?
    Eur Heart J. 2016.
    PubMed     Text format    


  58. SCHMIDT M, Lamberts M, Olsen AM, Fosboll E, et al
    Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
    Eur Heart J. 2016;37:1015-23.
    PubMed     Text format    


    March 2016
  59. YOSHINAGA M, Kucho Y, Nishibatake M, Ogata H, et al
    Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  60. CAIRNS JA
    The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?
    Eur Heart J. 2016.
    PubMed     Text format    


  61. CHEN Y, Zheng M, Lin K, Cui K, et al
    Mapping and surgical ablation of persistent atrial fibrillation in cor triatriatum sinister.
    Eur Heart J. 2016.
    PubMed     Text format    


  62. FRIBERG L, Tabrizi F, Englund A
    Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  63. FOX KA
    CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%.
    Eur Heart J. 2016;37:860-1.
    PubMed     Text format    


  64. MORSETH B, Graff-Iversen S, Jacobsen BK, Jorgensen L, et al
    Physical activity, resting heart rate, and atrial fibrillation: the Tromso Study.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  65. ASPBERG S, Chang Y, Atterman A, Bottai M, et al
    Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  66. WONG CX, Ganesan AN, Selvanayagam JB
    Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  67. DILLER GP, Brautigam A, Kempny A, Uebing A, et al
    Depression requiring anti-depressant drug therapy in adult congenital heart disease: prevalence, risk factors, and prognostic value.
    Eur Heart J. 2016;37:771-82.
    PubMed     Text format     Abstract available


    February 2016
  68. HIJAZI Z, Lindback J, Alexander JH, Hanna M, et al
    The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  69. SOTO-RUIZ RM, Bonaque Gonzalez JC, Fernandez Gasso L, Castillo Moreno JA, et al
    Persistent mitral and tricuspid insufficiency.
    Eur Heart J. 2016;37:712.
    PubMed     Text format    


  70. GANESAN AN, Chew DP, Hartshorne T, Selvanayagam JB, et al
    The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available



  71. CardioPulse: Ear stimulation for atrial fibrillation favoured at ESC Congress London.
    Eur Heart J. 2016;37:586.
    PubMed     Text format    


  72. TRUCHANOWICZ E, Kirchhof P
    CardioPulse: New perspectives for stroke prevention in atrial fibrillation.
    Eur Heart J. 2016;37:583-4.
    PubMed     Text format    


  73. TOFIELD A
    CardioPulse: Syncope and near drowning may signal sudden death risk.
    Eur Heart J. 2016;37:585.
    PubMed     Text format    


  74. OZKAN J
    CardioPulse: Gerhard Hindricks MD.
    Eur Heart J. 2016;37:580-1.
    PubMed     Text format    


  75. LUSCHER TF
    Managing arrhythmias: diagnosis and modern treatment.
    Eur Heart J. 2016;37:577-9.
    PubMed     Text format    


  76. STEFFEL J, Jais P, Hindricks G
    The year in cardiology 2015: arrhythmias and device therapy.
    Eur Heart J. 2016;37:587-93.
    PubMed     Text format    


  77. TANAWUTTIWAT T, Nazarian S, Calkins H
    The role of catheter ablation in the management of ventricular tachycardia.
    Eur Heart J. 2016;37:594-609.
    PubMed     Text format     Abstract available


  78. ANNEKEN L, Baumann S, Vigneault P, Biliczki P, et al
    Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking.
    Eur Heart J. 2016;37:640-50.
    PubMed     Text format     Abstract available


  79. KAMAKURA T, Wada M, Nakajima I, Ishibashi K, et al
    Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome.
    Eur Heart J. 2016;37:630-7.
    PubMed     Text format     Abstract available


  80. KOCH J, Lucke C, Gebauer R, Hindricks G, et al
    Accessory pathway ablation in childhood forming the substrate for ventricular tachycardia in adulthood.
    Eur Heart J. 2016;37:609.
    PubMed     Text format    


  81. STROKER E, de Asmundis C, Chierchia GB, Brugada P, et al
    Exercise-related Brugada pattern and monomorphic ventricular tachycardia in a patient with Brugada syndrome: interplay between body temperature, haemodynamics and vagal activity.
    Eur Heart J. 2016;37:655.
    PubMed     Text format    


  82. WEBB J, Frigiola A, Carr-White G, Chiribiri A, et al
    An unusual cause of ventricular tachycardia.
    Eur Heart J. 2016;37:654.
    PubMed     Text format    


  83. VEHMEIJER JT, Brouwer TF, Limpens J, Knops RE, et al
    Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  84. AUER J
    Fat: an emerging player in the field of atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format    


  85. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  86. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  87. SINGH SM, d'Avila A, Kim YH, Aryana A, et al
    The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study).
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  88. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016 Feb 4. doi: 10.1093.
    PubMed     Text format    


  89. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016 Feb 4. doi: 10.1093.
    PubMed     Text format    


  90. AQUILA I, Garcia A, Fernandez-Golfin C, Zamorano JL, et al
    It paces right but not in the right space!
    Eur Heart J. 2016;37:496.
    PubMed     Text format    


    January 2016
  91. VERHEUGT FW
    CardioPulse: Triple therapy for percutaneous coronary intervention in atrial fibrillation: a nightmare.
    Eur Heart J. 2016;37:326-7.
    PubMed     Text format    


  92. POZZOLI A, Mazzone P, Benussi S, Alfieri O, et al
    Incomplete surgical exclusion of the left atrial appendage.
    Eur Heart J. 2016;37:188.
    PubMed     Text format    


    December 2015
  93. AMIN AS, Wilde AA
    Genetic screening in acquired long QT syndrome? CAUTION: proceed carefully.
    Eur Heart J. 2015.
    PubMed     Text format    


  94. ITOH H, Crotti L, Aiba T, Spazzolini C, et al
    The genetics underlying acquired long QT syndrome: impact for genetic screening.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  95. LUSCHER TF
    Supraventricular and ventricular arrhythmias.
    Eur Heart J. 2015;36:3215-7.
    PubMed     Text format    


    November 2015
  96. HAEMERS P, Hamdi H, Guedj K, Suffee N, et al
    Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  97. LAU DH, Schotten U, Mahajan R, Antic NA, et al
    Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  98. TAYLOR J
    Uninterrupted novel oral anticoagulant therapy during atrial fibrillation ablation is safe.
    Eur Heart J. 2015;36:2272.
    PubMed     Text format    


    August 2015
  99. GORCSAN J 3RD, Sogaard P, Bax JJ, Singh JP, et al
    Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  100. GALIE N, Humbert M, Vachiery JL, Gibbs S, et al
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)End
    Eur Heart J. 2015.
    PubMed     Text format    


  101. LUSCHER TF
    Novel aspects of heart failure: from combined neurohormal blockade to embryonic stem cells.
    Eur Heart J. 2015;36:1937-9.
    PubMed     Text format    


    July 2015
  102. STONE GW, Adams DH, Abraham WT, Kappetein AP, et al
    Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  103. LIMA DA SILVA G, Pinto FJ, Almeida AG
    Invasive cardiac aspergillosis presenting as complete heart block in a patient with acute lymphoblastic leukaemia.
    Eur Heart J. 2015;36:1555.
    PubMed     Text format    


  104. SHARMA S, Merghani A, Mont L
    Exercise and the heart: the good, the bad, and the ugly.
    Eur Heart J. 2015;36:1445-53.
    PubMed     Text format     Abstract available


  105. POKORNEY SD, Granger CB
    Should patients on vitamin K antagonists be treated differently?
    Eur Heart J. 2015;36:1431-3.
    PubMed     Text format    


  106. O'DONOGHUE ML, Ruff CT, Giugliano RP, Murphy SA, et al
    Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillationdagger.
    Eur Heart J. 2015;36:1470-7.
    PubMed     Text format     Abstract available


  107. SEMSARIAN C, Ingles J, Wilde AA
    Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives.
    Eur Heart J. 2015;36:1290-6.
    PubMed     Text format     Abstract available


  108. ROELL W, Sinning JM, Werner N, Mellert F, et al
    How to re-shape a transcatheter heart valve.
    Eur Heart J. 2015;36:1287.
    PubMed     Text format    


    May 2015
  109. SAYED RH, Rogers D, Khan F, Wechalekar AD, et al
    A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis.
    Eur Heart J. 2015;36:1098-105.
    PubMed     Text format     Abstract available


    April 2015
  110. LUSCHER TF
    Arrhythmias, syncopy, and sudden death.
    Eur Heart J. 2015;36:829-31.
    PubMed     Text format    


  111. VENTECLEF N, Guglielmi V, Balse E, Gaborit B, et al
    Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines.
    Eur Heart J. 2015;36:795-805a.
    PubMed     Text format     Abstract available


    March 2015
  112. LUSCHER TF
    Heart failure: focus on co-morbidities, inflammation, and heart rate.
    Eur Heart J. 2015;36:635-7.
    PubMed     Text format    


  113. GLUKHOV AV, Kalyanasundaram A, Lou Q, Hage LT, et al
    Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.
    Eur Heart J. 2015;36:686-97.
    PubMed     Text format     Abstract available


  114. COTTENS D, Corteville B, Vanvinckenroye A, Schepens M, et al
    Moderate gradient with disproportional dyspnoea: multimodality imaging of funnel-shaped subaortic membrane.
    Eur Heart J. 2015;36:583.
    PubMed     Text format    


    February 2015
  115. LUBITZ SA, Singh JP
    Biventricular pacing: more is better!
    Eur Heart J. 2015;36:407-9.
    PubMed     Text format    


    January 2015
  116. LUSCHER TF
    Arrhythmias and pacing.
    Eur Heart J. 2015;36:131-2.
    PubMed     Text format    


  117. MURAKOSHI N, Xu D, Sairenchi T, Igarashi M, et al
    Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study.
    Eur Heart J. 2015;36:170-8.
    PubMed     Text format     Abstract available


  118. HEIDBUCHEL H, Hindricks G, Broadhurst P, Van Erven L, et al
    EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring.
    Eur Heart J. 2015;36:158-69.
    PubMed     Text format     Abstract available


  119. STOCKBURGER M, Boveda S, Moreno J, Da Costa A, et al
    Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population.
    Eur Heart J. 2015;36:151-7.
    PubMed     Text format     Abstract available


  120. BOGDAN S, Glikson M
    Physiological pacing: a moving target?
    Eur Heart J. 2015;36:141-2.
    PubMed     Text format    


    October 2014
  121. PELLICORI P, Zhang J, Lukaschuk E, Joseph AC, et al
    Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.
    Eur Heart J. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: